Delivery Order SPE2DB22D1106-SPE2DB24FFGU4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of Acamprosate Calcium DR 333 mg tablets, with a period of performance through November 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,064.52 firm fixed-price delivery order is for ACAMPROSATE CALC DR 333 MG TAB 180S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,774.20 firm fixed-price contract is for the delivery of 180-count bottles of Acamprosate Calcium 333mg tablets, a medication used to treat alcohol dependence. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of ACAMPROSATE CALC DR 333 MG TAB 180S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,455.70, is for the delivery of ACAMPROSATE CALC DR 333 MG TAB 180S, a medication used in the treatment of alcohol dependence. The contract has an ultimate completion date of March 6, 2025 and is a Firm Fixed Price Delivery Order. This contract is part of a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty thousand three hundred thirty-seven dollars to Amerisourcebergen Drug Corporation for the provision of three hundred thirty-three milligram tablets of acamprosate calcium in one hundred eighty count bottles. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over the period of September 19th through September 20th, 2023. The prime contractor, a division of...
- This federal contract award, valued at $4,131.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. The contract is for the delivery of 4,562,879,147 units of acetazolamide 250 mg tablets, a generic pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,953.54 Firm Fixed Price Delivery Order contract is for the supply of 4,564,743,033 units of Acetazolamide 250 mg tablets, a medication used to treat various medical conditions. The contract has an ultimate completion date of May 30, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,932.85, is a delivery order for the supply of Acetazolamide ER 500 mg capsules. The contract has an ultimate completion date of February 26, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order (DO) valued at $1,317.31 for the supply of 4,565,665,434 Clarithromycin 500 mg tablets in 60-count packages. The award was issued on September 3, 2024 by the Defense Logistics Agency (DLA) with a completion date of September 4, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts and indefinite delivery contracts...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FFGU4Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,455,650 units of the pharmaceutical product Acamprosate Calcium Delayed-Release 333 mg Tablets in quantities of 180 per bottle. The contract has a total ceiling value of $1,189.88 and was awarded by the Defense Logistics Agency (DLA), a defense agency. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 15, 2024. The contract does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various military treatment facilities, veterans' hospitals, and other federal healthcare providers through its extensive federal contract awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/14/24 |